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Osteoarthritis (OA) is the most common degenerative joint disorder. Multipotential stromal cells (MSCs) 
have a crucial role in joint repair, but how OA severity affects their characteristics remains unknown. 
Knee OA provides a good model to study this, as osteochondral damage is commonly more severe in 
the medial weight-bearing compartment compared to lateral side of the joint. This study utilised in 
vitro functional assays, cell sorting, gene expression and immunohistochemistry to compare MSCs 
from medial and lateral OA femoral condyles. Despite greater cartilage loss and bone sclerosis in medial 
condyles, there was no significant differences in MSC numbers, growth rates or surface phenotype. 
Culture-expanded and freshly-purified medial-condyle MSCs expressed higher levels of several 
ossification-related genes. Using CD271-staining to identify MSCs, their presence and co-localisation 
with TRAP-positive chondroclasts was noted in the vascular channels breaching the osteochondral 
junction in lateral condyles. In medial condyles, MSCs were additionally found in small cavities within 
the sclerotic plate. These data indicate subchondral MSCs may be involved in OA progression by 
participating in cartilage destruction, calcification and sclerotic plate formation and that they remain 
abundant in severe disease. Biological or biomechanical modulation of these MSCs may be a new 
strategy towards cartilage and bone restoration in knee OA.
Osteoarthritis (OA) is the major cause of chronic pain and disability and its incidence is predicted to increase in 
coming decades1,2. Historically described as a degenerative disease of cartilage, OA is now viewed as a disease of 
the whole joint with characteristic abnormalities to subchondral bone, and no disease-modifying drugs available 
to induce remission3. Abnormalities in OA bone such as subchondral plate sclerosis and bone marrow lesions 
(BMLs) are anatomically ‘mapped’ to the areas of abnormal joint loading and cartilage denudation4, suggesting 
that the disease process affects the osteochondral unit as a whole, rather than cartilage or bone separately5–8.
In a healthy osteochondral unit, some cross-talk between cartilage and subchondral bone cells occurs for bal-
anced mechanotransduction and nourishment of deep cartilage layers. Multipotential stromal cells (MSCs), the 
precursors of both osteocytes and chondrocytes, are present in the subchondral bone9 but also in the surrounding 
synovium and synovial fluid (SF)10, with early cartilage lesions likely to be repaired by joint resident MSCs11. 
However, in OA, damage to the osteochondral junction may lead to altered molecular exchanges and activation 
of subchondral bone MSCs5,12.
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We have previously shown the presence of MSCs in healthy and arthritic SF, and their numerical increase in 
OA compared to arthroscopically normal joints10. However, despite their apparent increase as the disease pro-
gresses13, cartilage lesions in OA continue to deteriorate suggesting that locally available SF MSCs have reduced 
joint repair potentials, possibly due to their impaired attachment to cartilage14, reduced chondrogenic ability15 or 
persistent abnormal joint mechanical loading4. MSCs resident in OA subchondral bone may also be affected by 
the osteoarthritic process, this time as a result of altered joint biomechanics or the breached osteochondral junc-
tion. For example, using a mouse anterior cruciate ligament transection (ACLT) model of OA, Zhen et al. have 
recently documented an abnormal recruitment and osteogenic commitment of subchondral bone MSCs leading 
to aberrant bone formation and BMLs16. In agreement, we previously demonstrated that MSCs were more numer-
ous in subchondral BMLs in late-stage hip OA patients17 and had gene expression bias towards bone formation as 
opposed to bone resorption17, compared to MSCs from the non-BML areas. As MSCs are the earliest precursors 
of osteoblasts and chondrocytes, these abnormalities in subchondral bone MSCs could be directly responsible for 
the formation of sclerotic bone later in disease18, instead of rebuilding new cartilage. Present immediately beneath 
chondral lesions17, these osteogenically-committed MSCs could also influence the remaining cartilage metabo-
lism. Whether the same MSC behaviour can be seen in knee OA subchondral bone MSCs, remains unknown.
Human knee OA provides a potentially unique model for the study of MSCs in joint repair, homeostasis and 
OA progression. This is because the anatomical structure and biomechanical configuration of the knee is typically 
associated with much more severe cartilage loss on the predominantly weight-bearing medial compartment4,19–21. 
The aim of this study was therefore to investigate and compare the numbers, topography and gene expression 
profiles of subchondral bone-resident MSCs from medial and lateral femoral condyles from the same patient. 
We additionally hypothesised that due to increased molecular exchanges through damaged osteochondral junc-
tion, parallel gene expression alterations can be seen in medial condyle chondrocytes. As gene expression in 
bone-resident MSCs is known to be affected by culture expansion22–24, the analysis was performed on MSCs 
directly taken from their native environment as well as following culture expansion.
Results
Histological assessment of tissue damage in medial and lateral femoral condyles. Whole 
medial and lateral condyle specimens were decalcified in EDTA and the cartilage damage assessed using the 
OARSI OA cartilage histopathology scoring system25 (Fig. 1a,b). Four out of five medial condyles had OARSI 
score of 20 indicating maximum damage characterized by denuded bone in more than 50% of the specimen sur-
face. Lateral condyles were more variable, with cartilage damage scores ranging from 1.5 to 15 (15 corresponding 
to the one valgus deformity patient in our cohort) (Fig. 1b). Superficial fibrillation or simple fissures in the outer 
cartilage areas were most commonly observed in lateral condyles, however, a focal area of denuded bone was 
Figure 1. Histological assessment of tissue damage in osteoarthritic femoral condyles. (a) Example 
macroscopic (top) and microscopic (bottom) images of safranin-O stained sections illustrating the spectrum 
on cartilage damage in both medial and lateral condyles. In the medial condyles microscopic images show 
regions from different donors ranging from surface fibrillation and fissures with cartilage matrix loss (far left) 
to complete cartilage loss and sclerotic plate formation (far right). In lateral condyles, microscopic images show 
matrix loss with some surface abrasion (far left) to complete cartilage loss (in a valgus patient) with no evidence 
for bone sclerosis). (b) OARSI grading of the whole medial and lateral condyle surfaces showing significantly 
less cartilage damage in lateral condyles. (c) Example microscopic images of subchondral bone from different 
donors illustrating the increased bone anabolic response to loss of cartilage on the medial compared to the 
lateral condyle. (d) Bone area analysis of these areas demonstrating the increase in bone area as a percentage of 
total area in the medial compartment. *p < 0.05, n = 5 donors. Horizontal bars show medians.
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seen in the valgus donor (Fig. 1a, lateral). As expected, subchondral bone area measured as a percentage of total 
area was higher in medial compared with lateral condyles (Fig. 1c,d), and the highest in the sclerotic areas that 
were fully denuded of cartilage (Fig. 1c, medial). Altogether these data were consistent with previous findings 
indicating much more pronounced osteochondral damage and therefore more severe disease in medial condyles 
of patients with a varus deformity of the knee19,21.
Comparison of subchondral MsC numbers and in vitro functional capacity between medial and 
lateral condyles. In a cohort of 11 of varus patients, analysis of the colony-forming capacity of cell extracts 
obtained from collagenase digestion, revealed no difference in the frequency of MSCs measured as a percentage 
of CFU-Fs in relation to total extracted cells (Fig. 2a). Similarly, no difference was found in the numbers of CFU-F 
per gram of bone (data not shown). Cultures generated from the extracted cells possessed standard MSC surface 
phenotype, with no differences in CD73, CD90 and CD105 expression levels (Fig. 2b), and exhibited similar 
growth rates (Fig. 2c). No trends for a differentiation bias between medial and lateral condyle MSCs were found 
following tri-lineage differentiation, however large patient variability was observed. Differentiation results for one 
patient are shown in Fig. 2d.
Interestingly, using a scratch migration assay, lateral condyle MSCs from all patients showed slightly higher 
motility rates (measured as percentage of scratched area covered by cells after 12 hours, (Fig. 2e,f) whereas their 
angiogenesis-support capability appeared to be similar (Supplementary Fig. 1).
Gene expression differences between medial- and lateral condyle MSCs. Gene expression (for 
95 transcripts selected based on their involvement in MSC tri-lineage differentiation, chondroprotection, car-
tilage metabolism, genetic association with OA, or OA progression17,26–30) was first compared between culture 
expanded MSCs and chondrocytes to assess whether the selected gene panel reflected the cell identity/function. 
Irrespective of their condyle origin, cultured MSCs and chondrocytes separated from each other when gene 
expression profiles were analyzed using an unsupervised hierarchical clustering approach (Fig. 3a), with 30 and 
18 genes expressed at higher level in MSCs and chondrocytes, respectively (Supplementary Table 1). Of note, 
highly expressed genes in MSCs included classical bone structural molecules such as IBSP (bone sialoprotein) and 
COL1A1 (collagen type I alpha 1 chain), while structural cartilage protein COMP (cartilage oligomeric matrix 
protein) was only expressed in chondrocytes (Supplementary Table 1).
The analysis was next performed between medial and lateral condyles MSCs from the varus deformity patients 
(Fig. 3b). Not all of the genes were expressed in all samples, therefore an unpaired statistical analysis was first 
performed, followed by paired tests when possible (i.e. when > 6 pairs could be used). Four genes GREM1 (grem-
lin1), ANKH (inorganic pyrophosphate transport regulator), TGFBR2 (transforming growth factor beta recep-
tor 2) and SERPINE1 (serpin family E member 1) out of 95 were found to be higher in medial condyle MSCs 
(p < 0.05 for all 4 genes, using both unpaired and paired tests, Fig. 3b). The largest differences were found for 
GREM1 (median fold 2.9) and ANKH (median fold 2.1). Additionally, STMN2 (stathmin 2) and PTHLH (par-
athyroid hormone like hormone) displayed low detection frequency in lateral condyle MSCs indicating strong 
differential expression (Fig. 3b). Interestingly, low PTHLH detection frequency in lateral condyles MSCs was 
preferentially seen in female patients compared to male patients (detected in 2 out of 6 females compared to 4 out 
of 5 males). None of the genes tested showed significantly higher expression in lateral condyle MSCs.
Gene expression differences between medial- and lateral condyle chondrocytes. To investi-
gate if differentially-expressed genes were specific to MSCs or also observed in chondrocytes thus indicating 
co-regulation in both cell types, gene expression levels were compared between medial and lateral condyle chon-
drocyte cultures of the varus deformity patients (Fig. 3c). A different set of genes was differentially expressed, 
with 3 genes over-expressed in medial condyle chondrocytes: RUNX2 (runt-related transcription factor 2), PPARg 
(peroxisome proliferator activated receptor gamma) and SERPINE1 (Fig. 3c) while again, none were found to 
be higher in lateral condyle chondrocytes. Altogether, only one gene, SERPINE1, showed a similar differential 
expression between the condyles in both MSCs and chondrocytes.
Gene expression differences between uncultured medial- and lateral condyle CD45−CD271+ 
MSCs. It has been documented that even minimal expansion of MSCs in standard conditions leads to changes 
in gene expression22,31,32. To investigate if gene expression differences between medial and lateral condyle MSCs 
identified using cultured cells were also measurable in vivo, we proceeded with gene expression analysis on 
CD45−CD271+ sorted cells (Fig. 4a), a recognized phenotype of native human bone-resident MSCs33,34 from 
the varus deformity patients. Consistent with CFU-F data (Fig. 2a), no statistically significant differences in the 
proportions of CD45−CD271+ cells was found between medial and lateral condyles’ tissue digests (Fig. 4b).
CD45+CD271− hematopoietic lineage cells (HLCs) sorted from the same tissue digests (Fig. 4a) were used 
as a negative control population and clustered separately from CD45−CD271+ MSCs (Fig. 4c). As expected, 
genes involved in immune response and cell migration/chemotaxis (for example, IL1B (interleukin 1 beta) and 
CCL5 (C-C motif chemokine ligand 5)) were expressed at higher levels in CD45+CD271− HLCs (Supplementary 
Table 2), while genes involved in mesenchymal lineage differentiation (for example, SP7, SOX9 (SRY-box 9) and 
PPARg) were expressed at higher levels in CD45−CD271+ MSCs (Supplementary Table 2).
When the levels of expression were compared between medial and lateral condyle CD45−CD271+ MSCs, 
most of the genes did not show differential expression but three genes were significantly higher in medial condyle 
MSCs: GREM1, STMN2 and PTHLH (Fig. 4d), all of which were first found on our cultured MSC screen (Fig. 3b). 
Again, no genes were found to be higher in lateral CD45−CD271+ MSCs.
The topography of CD271+ MsCs in the osteochondral areas of medial and lateral con-
dyles. Although we did not find significant differences between medial and lateral condyles in the proportions 
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Figure 2. Functional analysis of subchondral bone MSCs from medial and lateral condyles. (a) Comparison of 
MSC frequency measured as a proportion of colony forming units fibroblast in relation to total enzymatically-
extracted cells for donor matched samples. (b) Phenotypic profile of culture expanded medial and lateral 
condyle derived MSCs indicating no differences in the expression of standard MSC markers. (c) Comparison of 
growth rates of medial and lateral condyle derived MSCs measured as population doubling times (in days) for 
donor matched samples. (d) Example images of differentiation assays performed with donor matched samples. 
Osteogenic images (Osteo) show positive alkaline phosphatase staining on day 14 post osteogenic induction, 
adipogenesis assay (Adipo) shows accumulation of Oil Red-O stained lipid vesicles on day 14 post adipogenic 
induction and toluidine blue staining of chondrogenic pellet cultures (Chondro) shows accumulation of 
proteoglycans (purple) on day 21 post chondrogenic induction. (e) Examples migration assay images from 
baseline (top) and 12 hours post scratch (bottom) wound for medial and lateral MSCs. Black line indicates the 
migrating front of the cells. (f) Analysis of migration assay images for donor matched medial and lateral MSCs 
showing the percentage of wound coverage by migrating cells after 12 hours (relative to the corresponding 
0 hour area), and showing a trend for higher motility by lateral condyle MSCs.
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Figure 3. Gene expression analysis of culture expanded, medial and lateral condyle derived MSCs and 
chondrocytes. (a) Cluster analysis between chondrocytes (CH) and MSCs from both the medial and lateral 
femoral condyles illustrating clear clustering of MSCs away from chondrocytes. Data were normalized to the 
housekeeping gene HPRT and log2 transformation and data filtering were performed according to standard 
methods described in Churchman et al.22. Scores were assigned as follows: black = 1, red > 1, green < 1; 
grey = missing data (below detection). (b) Differentially expressed genes between medial and lateral MSCs with 
statistically significant differences in donor-matched and non-matched analysis. LD indicates transcripts which 
were rarely expressed (in < 50% samples). (c) Differentially expressed between medial and lateral chondrocytes 
with statistically significant differences in donor-matched and non-matched analysis. *p < 0.05; **p < 0.01. 
Horizontal bars show medians. REU: relative expression units (relative to housekeeping HPRT).
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Figure 4. Native subchondral bone MSCs gene expression analysis. (a) Flow cytometry dot plots illustrating 
sorting gates for CD45−CD271+ MSCs and CD45+ CD271− haematopoietic lineage cells (HLCs) together with 
representative frequencies of MSCs and HLCs measured as a percentage of total live cells (square boxes) for donor 
matched medial and lateral condyles. (b) Comparison of CD45− CD271+ MSC frequency for donor matched 
samples measured by flow cytometry. Y-axis represents CD45− CD271+ cells as percentage of total live cells. (c) 
Cluster analysis between CD45 + HLCs and CD271 + MSCs from both the medial and lateral femoral condyles, 
and illustrating clear clustering of MSCs away from HLCs. Data were normalized to the housekeeping gene 
HPRT and log2 transformation and data filtering were performed according to standard methods described in 
Churchman et al.22. Scores were assigned as follows: black = 1, red > 1, green < 1; grey = missing data (below 
detection). (d) Selected genes with differential expression patterns between medial and lateral condyle derived 
CD45-CD271 + native MSCs. LD indicates transcripts which were rarely expressed (in < 50% samples). *p < 0.005. 
Horizontal bars show medians. REU: relative expression units (relative to housekeeping HPRT).
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of CFU-Fs (Fig. 2a) or CD45−CD271+ cells (Fig. 4b), following their enzymatic extraction from the subchondral 
bone, it is possible that damage-specific topographical niches for these cells could be found in situ (Fig. 5). In the 
medial condyles, where large (>50%) areas of the articulating surface displayed fully denuded bone, CD271+ cells 
were found in the remaining bone cavities of the sclerotic plate, typically in stromal, bone-lining and perivascu-
lar regions (Fig. 5a, areas 1, 2 and 3, respectively). Strong CD271 positivity was also found in the stromal tissue 
within occasional subchondral cysts (Supplementary Fig. 2). In the lateral condyles of the varus knees, CD271+ 
cells were commonly observed within vascular channels invading into the articular cartilage (Fig. 5b, areas 1 and 
i), as well as lining trabeculae (area 3). Interestingly, CD271+ cells also were often found near TRAP+ chondro-
clasts, and parallel Safranin O staining of adjacent sections clearly indicated cartilage replacement by new bone 
in these particular areas (Fig. 5c). This ‘vascular channel’ MSC topography was also seen in less damaged areas of 
Figure 5. Topography of CD271+ MSCs in OA femoral condyles. (a) Immunohistochemistry of medial 
condyle joint surface showing the distribution of CD271+ MSCs within the sclerotic area of denuded bone. 
Magnified images show corresponding areas of CD271 staining in stromal tissue (1), on bone lining (2) 
and in perivascular regions (3). Additional images from different donors show isolated CD271 positivity in 
chondrocytes (i, arrows), bone lining (ii) and perivascular (iii) staining. (b) Immunohistochemistry of the 
lateral condyle joint surface showing the distribution of CD271+ MSCs in the lateral condyle. Magnified images 
shown corresponding (1–3) areas and features from other donors shown in (i-iii). Vascular channels invading 
the cartilage (1 and i) were a common feature in all donors as was the typical bone lining (2, 3 and ii) appearance 
of CD271+ MSCs. No CD271 was seen in chondrocytes, however some positivity was seen in stromal tissue 
in areas of cartilage damage (iii). (c) Adjacent Safranin O (Saf-O), TRAP and CD271 stained tissue sections 
showing co-localisation of TRAP + chondroclasts and CD271+ MSCs in a region of abundant vascular/bone 
invasion into the articular cartilage. Safranin-O staining shows areas of GAG depletion and bone invasion 
(blue). The corresponding CD271 and TRAP images indicate that these cartilage erosion and bone formation 
processes may be mediated by chondroclasts and neighboring MSCs, respectively. Magnified images show 
specific TRAP and CD271 co-localisation with arrow heads highlighting additional TRAP + cells.
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the medial condyles, directly underneath any remaining articular cartilage and likely reflecting a common early 
process in the OA knee joint, where articular cartilage still remains and covers the bone (not shown). Similar 
immunohistological findings were also observed in the proximal tibial plateau samples from the varus knees 
(Supplementary Fig. 3).
Discussion
This study evaluated numerical, topographical and gene expression changes in subchondral bone MSCs in knee 
OA, in relation to osteochondral damage progression, by comparing the medial and lateral femoral condyles 
from the same patients with varus deformity knee OA. This is the most common type of knee OA, in which 
the mechanical load is preferentially transmitted to the medial compartment of the knee35,36. In a rarer valgus 
deformity type, the load-bearing axis passes lateral to the knee, and the resulting force increases on the lateral 
compartment36. Our data reveal no significant differences in subchondral bone MSC numbers between medial 
and lateral condyles of varus patients, as well as their comparable growth rates and trilineage capacities in vitro. A 
broadly similar pattern of MSC topography was seen in both condyles with their notable presence in the vascular 
channels breaching the osteochondral junction in early lesioned areas and within subchondral bone cavities. 
However, medial condyles MSCs were also present in small sclerotic plate cavities, and had notable gene expres-
sion alterations, first identified in in vitro-expanded MSC, and then confirmed using uncultured sort-purified 
CD45−CD271+ MSCs. To our best knowledge, this is therefore the first study to describe the topographies and 
identify novel genes specifically up-regulated in MSCs from more-damaged, sclerotic subchondral bone areas in 
human knee OA.
Gene expression data identified STMN2, PTHLH and GREM1 as the three most consistent upregulated genes 
in the more damaged, medial condyle MSCs screened on both in vivo and in culture-expanded MSCs. These 
genes were not differentially expressed in chondrocytes or HLCs indicating that the observed differences were 
MSC-specific. GREM1 has been recently shown as a marker of osteochondral skeletal stem cells in mice37, and 
involved in the regulation of chondrocyte hypertrophy, osteogenic differentiation and endochondral ossifica-
tion38,39. PTHLH has been initially identified as OA susceptibility gene, and later shown to be involved in the 
regulation of both bone and cartilage development40,41, including chondrocyte hypertrophy42–45. PTHLH gene 
encodes parathyroid hormone related protein (PTHrP) which has multiple functions including its anabolic activ-
ity on bone cells, and is used for osteoporosis treatment46. Its reduced expression in more OA damaged condyles, 
and particularly in female patients, suggests that PTHLH can be a good candidate gene for further analysis in 
larger, gender split patient cohorts.
Most exciting, is our finding of an up-regulation in medial condyle MSCs of STMN2, a small phosphoprotein 
involved in the neuronal microtubule dynamics, proliferation, differentiation and migration47,48, and upregu-
lated by nerve growth factor49. Its role in skeletal tissue development was first demonstrated by Chiellini et al.49 
who showed that STMN2 was expressed by MSCs that undergone osteogenic but not adipogenic differentiation. 
A recent study has also documented the significant up-regulation of STMN2 in the BML regions of knee OA 
patients26, complementing our present findings. Another gene, ANKH was upregulated in medial condyle cul-
tured MSCs, and narrowly missed significance in uncultured CD45−CD271+ cells. This molecule also plays an 
important role in the regulation of differentiation and mineralization in both bone and cartilage50.
Altogether, this gene expression pattern indicates potential MSC involvement in the processes of cartilage 
calcification, bone formation and mineralisation, supporting previous observations16,51 and our histological find-
ings on the topography of CD271+ cells in situ where such cells remained present in sclerotic plate cavities. As a 
broadly similar pattern of MSC topography was seen in medial tibial plateaus and in our hip OA study17, this indi-
cates subchondral bone MSC involvement in the disease progression in both major types of human OA. While 
no up-regulated genes were found in lateral condyle MSCs based on the gene panel selected for this study, our 
histological observations showed the presence of CD271+ MSCs in the vascular channels that migrate upwards 
and breach the osteochondral junction in early disease stages, which were more apparent in lateral condyles. This 
is in agreement with our functional data indicating higher motility of lateral compared to medial condyle MSCs.
Based on animal model studies16, and our previous hip OA findings17, we expected to detect higher numbers 
of MSCs in more damaged, medial condyles. Although histological assessment of cartilage damage confirmed an 
overall more damaged status of medial condyles in varus patients4,20,52, both medial and lateral condyles showed 
regional variations in the amount of damage, which may have affected our results. A more selective, ‘region-based’ 
approach, as undertaken in recent microarray studies28,29,53, may have been more accurate, but this was deemed 
technically unattainable due to the small amounts of bone available for subsequent isolation and sorting of rare 
MSCs. However, in contrast to the above-mentioned microarray gene expression studies26,28,29,53, we were able to 
assign up- or down-regulated gene expression to specific cell types, i.e. MSCs or HLCs further clarifying the role 
of MSCs in OA pathogenesis.
Finally, we used cultured MSCs and chondrocytes to test a hypothesis of gene expression co-regulation in 
OA28, as a result of increased molecular exchange through the breached osteochondral junction. Whereas a little 
overlap between differentially regulated genes in both MSCs and chondrocytes was found, SERPINE1 was one 
molecule showing parallel up-regulation in medial condyle MSCs and chondrocytes. Consistent with our find-
ings SERPINE1 protein was found to be more abundant in the supernatants of cultured osteoblasts derived from 
sclerotic areas of OA subchondral bone54, however in contrast to our study, its mRNA expression was found to be 
lower in medial condyle chondrocytes, compared to healthy or lateral condyle chondrocytes in another study55. 
These differences can be partially explained by the fact, that SERPINE1 expression is downregulated in chondro-
cyte culture56.
In summary, this study documents the presence, topography and gene expression profile of the subchondral 
bone MSCs in femoral condyles of the most common, varus type of human knee OA. It showed that even in late 
disease stages, there is no obvious numerical MSC defect on the most worn medial joint compartment, however 
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medial condyle MSCs had characteristic upregulation of several ossification-related genes. Further studies are 
needed to establish whether these differences in MSCs are due to an ongoing, albeit aberrant, tissue repair process 
or a reaction to mechanical over-stress due to alterations in prevalent mechanical forces. These questions can be 
further addressed by looking at the topography of MSCs in relation to a newly-formed osteoid or early osteocytes, 
as shown in our recent study in hip OA patients57, and using larger cohorts of varus and valgus OA patients. As 
shown here, native subchondral bone MSCs remain present in late disease stages and are therefore available for 
biomechanical or therapeutic targeting, and we identified several gene candidates such as GREM1, PTHLH and 
STMN2, for such targeting.
Further work is also needed to establish if biomechanical (such as knee joint distraction14,58) or biological 
stimulation of these MSCs (such as direct or extracellular vesicle-based microRNA modulation)59,60 can result 
in gene expression changes in preference of cartilage tissue formation and subchondral bone restoration. Also, a 
better understanding of cellular and molecular events leading to vascular channel formation and upward migra-
tion in early disease stages, and the role of MSCs in these processes, could lead to novel therapies for early OA.
Materials and Methods
Patient samples. Ethical approval for this study was obtained from the Yorkshire & The Humber - South 
Yorkshire Research Ethics Committee (14/YH/0087), in compliance with the Helsinki Declaration of ethical prin-
ciples for medical research involving human subjects. Seventeen patients (median age 72 years old, range 56–83) 
were included in this study after signing informed consent, who all underwent total knee arthroplasty. Of these 
patients, all but two had a varus deformity indicating the medial aspects of the joint were the prominent weight 
bearing surface. All the patients met the American College of Rheumatology criteria for knee osteoarthritis (OA) 
(Altman, 1986) and gave written informed consent. Exclusion criteria were: history of inflammatory arthritis, 
metastatic cancer or other disorders affecting bone.
From all arthroplasties, intact femoral condyle samples were collected in saline and transferred to the labora-
tory immediately upon receipt.
Histology and immunohistochemistry. Whole condyles from five knee replacement surgeries (four with 
varus and one with valgus deformity) were fixed in 3.7% formaldehyde (Thermofisher Scientific, UK) for 1 week, 
decalcified using 0.5 M ethylenediaminetetraacetic acid (EDTA; Sigma, USA) for at least 6 months (dental x-rays 
used to assess extend of decalcification), re-fixed in formaldehyde for further 2 days before embedding in paraffin 
blocks, as described for tibial plateaus51. Safranin O-Fast Green (SO-FG) and Tartrate-resistant acid phosphatase 
(TRAP) staining were performed on 5–7 µm thick sections of the whole condyles, according to standard protocols 
(all reagents from Sigma). Stained slides were scanned using Leica Aperio AT2 (Leica, Germany) and images were 
taken with Aperio Imagescope (Leica).
For each pair of condyles, the ratio of bone area to total area of subchondral bone was assessed on SO-FG 
images using ImageJ 1.51t software (National Institutes of Health, USA), as previously described17. Briefly, at 
least 4 non-overlapping areas (5 mm width × 1 mm height) directly underneath the cartilage were analysed and 
averaged, and the bone area was calculated as a percentage of total area (mean ± SD). Cartilage damage across 
the whole condyle (sagittal plane) was scored by agreement of two independent observers using the OARSI OA 
cartilage histopathology scoring system25. This scoring system is widely used16,61,62 for microscopic assessment 
as it takes into account both the severity and the extent of the lesion over the measured surface, which in this 
study was over the whole femoral condyle. TRAP-positive chondroclasts were also identified by two independent 
observers, as previously described63.
Immunohistochemical staining for CD271-positive cells, the native MSC phenotype in bone33,34,64,65, was per-
formed using monoclonal mouse anti-human antibody (clone ME20.4; Invitrogen, USA) at 1:200 dilution fol-
lowed by incubation with horse radish peroxidase (HRP) and 3,3′-diaminobenzidine tetra hydrochloride (DAB) 
from the EnVision + Dual Link System-HRP (DAB+) (Dako, Agilent, USA), as previously described17. Sections 
were counterstained with hematoxylin and the slides scanned using Leica Aperio AT2.
Isolation and culture of MSCs and chondrocytes. Using varus patients samples, articular cartilage was 
harvested from lateral and medial condyle surfaces using a scalpel, and chondrocytes were isolated as described 
before66. Briefly, cartilage was minced using a scalpel and digested overnight with 3,000 units of collagenase/g of 
tissue (Worthington Biochem Corp, USA). Homogenate was filtered with 22 µm cell strainer (Corning Inc., USA) 
before centrifugation at 450 × g for 10 minutes, followed by 5 minutes of 1x trypsin digestion. Chondrocytes 
were expanded in Dulbecco’s Modified Eagle’s Medium (DMEM; ThermoFisher Scientific, USA) with 10% fetal 
bovine serum (FBS; BioSera, France) and 1% penicillin/streptomycin (P/S; ThermoFisher Scientific). Media were 
changed twice a week and subculture was performed when cells reached 80% confluence, and passaged to p1.
For MSC isolation, the remaining subchondral and trabecular bone after removal of cartilage was weighted 
and minced mechanically into small fragments with a rongeur and digested for four hours with 3,000 units of 
collagenase/g, as previously described17. The liquid fraction was then filtered through 22 µm cell strainer before 
centrifugation at 450 × g for 10 minutes to pellet the extracted cells. Following counting, the cells were used 
for CFU-F assay, culture expansion or frozen in liquid nitrogen for subsequent cell sorting experiments. MSC 
cultures were established by seeding 106 cells in 25 cm2 flasks (Corning Inc.) containing StemMACS™ MSC 
Expansion Media (Miltenyi Biotec, Germany) supplemented with 1% P/S. Media were changed twice a week, 
cells were split when reached 80% confluence and passaged up to p5.
CFU-F assay. To enumerate MSCs, the colony-forming unit-fibroblast (CFU-F) assay was performed using 
freshly-digested cells seeded at a density of 5 × 103 into 60 mm culture dishes (Corning Inc.) with StemMACS™ 
MSC Expansion Media in duplicate. Media was changed twice a week and after 10 days, the dishes were fixed 
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with 3.7% formaldehyde and stained with methylene blue to visualize colonies, as previously described67. Colony 
numbers from duplicate dishes were counted, averaged and converted to CFU-F/106 cells (or per gram of bone), 
and compared between medial and lateral condyles for each patient.
Purification of uncultured subchondral bone MSCs by cell sorting. Cell sorting was performed 
using frozen/thawed cells obtained directly after bone digestion, as described before9,22. In brief, cells were thawed, 
re-suspended in fluorescent activated cell sorting (FACs) buffer and incubated in a blocking buffer (Miltenyi 
Biotec, UK) for 10 minutes before staining with the following antibodies: CD271 (allophycocyanin, APC; Miltenyi 
Biotec) and CD45 (Fluorescein-5-isothiocyanate, FITC; BD Biosciences, UK). Dead cells were excluded following 
staining with 7-AAD (Sigma) immediately prior to sorting. Cell populations: MSCs (CD45−CD271+) and control 
haematopoietic lineage cells (HLCs) (CD45+CD271−) were sorted into 2 separate tubes containing lysis buffer for 
RNA isolation (Norgen Bioteck Corp., Canada), using a BD Influx cell sorter (BD Biosciences, USA).
Gene expression analysis. RNA was isolated from sorted CD45−CD271+ MSCs and control HLCs 
(donor-matched samples from lateral and medial condyles), using the total RNA Purification kit (Norgen Bioteck 
Corp.), following manufacturer’s instructions. Also, RNA was isolated from donor- and condyle matched passage 
1 (p1) MSCs (thereafter referred to as cultured MSCs/cMSCs) and p1 chondrocytes (CH). Gene expression was 
performed using the 48.48 IFC (Integrated Fluidic Circuit), using recommended reagents (Fluidigm Corporation, 
USA), and standard TaqMan Assays (Thermofisher Scientific) following manufacturer’s recommendations. The 
95 genes of interest were chosen based on their involvement in MSC trilineage differentiation, chondroprotec-
tion, cartilage metabolism, genetic association with OA, or OA progression as identified from genome-wide scr
eens17,26–28,30,53 (Supplementary Table 3). Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) was used as a 
housekeeping gene to calculate relative expression values.
Reverse transcription was performed to convert RNA to cDNA followed by 12 pre-amplification cycles for 
sorted and cultured cells, using a mixture of 96 Taqman gene expression assays (Supplementary Table 1). Diluted 
pre-amplified cDNAs were mixed with sample loading buffer (Fludidigm Corporation) and Taqman Universal 
PCR Master mix (Applied Biosystems, USA) before transferring to the Dynamic 48.48 IFC sample compartment. 
Each of the 96 Taqman assays were independently mixed with assay loading buffer (Fludidigm Corporation) 
and transferred to the wells of the relevant compartment on the IFC. The IFC was then run on the Biomark Real 
Time PCR System using a GE 48 × 48 Standard v1 PCR thermal protocol. Data was analysed using BioMark 
Gene Expression Data software and normalized to the housekeeping gene. Genes differentially expressed between 
MSCs, HLCs and chondrocytes were further scrutinized for hierarchical clustering analysis using Cluster 3.0 
software and Java TreeView22. For cluster analysis, only genes expressed in ≥80% of samples and cultures who 
expressed ≥60% of all genes were included. Individual protein information and protein network analysis was 
obtained using the String database68.
Tri-lineage differentiation assays. Osteogenic, chondrogenic and adipogenic capacities of medial and 
lateral condyle MSCs were assessed and compared, as previously described10. In brief, MSCs were each seeded 
in triplicate wells of 24 well-plates (Corning) for osteogenic and adipogenic differentiation. Osteogenic media 
contained DMEM supplemented with 10% FBS, 100 nM dexamethasone, 0.05 mM ascorbic acid and 100 mM 
β-glycerosphosphate (all from Sigma). Cells were cultured and osteogenic differentiation was assessed by Alkaline 
phosphatase activity staining.
MSC adipogenic differentiation was assessed by Oil Red O staining, after culture in adipogenic media: DMEM 
supplemented with 12.5% FBS, 12.5% horse serum, 0.5 mM isobutylmethylxanthine, 60 µM indomethacin and 
0.5 mM hydrocortisone (all from Sigma). Chondrogenic differentiation was performed in 3D-pellet culture in 
ChondroDiff media (Miltenyi Biotec) and glycosaminoglycan (GAG) content was evaluated in 5μm sectioned 
pellets stained with Toluidine Blue17.
MSC motility assay. In vitro motility of MSCs was assessed using a scratch assay as described before69. Briefly, 
MSCs were grown to confluence in a 6-well plate in StemMACS culture media. After removing the media, the cell 
monolayer was scratched with a sterile 200 µl pipette tip and washed with PBS before replacing with StemMACS™ 
MSC Expansion Media. At least 3 images along the open scratch were taken at 0 and 12 hours. Measurements along 
the scratch were averaged and percentage area closed was calculated using ImageJ software, normalized to time 0, 
and compared between medial and lateral condyles.
Statistics. Results were analysed using Mann-Whitney and Wilcoxon Signed Rank tests for unpaired and 
paired data, respectively. The statistical analysis was performed using Prism software (version 7.0 a; GraphPad). 
The difference between the groups was considered as statistically significant if the p value < 0.05.
Data Availability
The gene expression array data that support the findings of this study is available from the authors upon request.
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